OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Suitability of potyviral recombinant virus-like particles bearing a complete food allergen for immunotherapy vaccines
Diego Pazos‐Castro, Clémence Margain, Zulema González‐Klein, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Diego Pazos‐Castro, Clémence Margain, Zulema González‐Klein, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Showing 13 citing articles:
Feast for thought: A comprehensive review of food allergy 2021-2023
Irene Bartha, Noorah Almulhem, Alexandra F. Santos
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 3, pp. 576-594
Open Access | Times Cited: 30
Irene Bartha, Noorah Almulhem, Alexandra F. Santos
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 3, pp. 576-594
Open Access | Times Cited: 30
Ara h 2–expressing cucumber mosaic virus–like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individuals
Janice A. Layhadi, Sviatlana Starchenka, Pieter‐Jan de Kam, et al.
Journal of Allergy and Clinical Immunology (2025) Vol. 155, Iss. 1, pp. 153-165
Closed Access
Janice A. Layhadi, Sviatlana Starchenka, Pieter‐Jan de Kam, et al.
Journal of Allergy and Clinical Immunology (2025) Vol. 155, Iss. 1, pp. 153-165
Closed Access
A Multifunctionalized Potyvirus-Derived Nanoparticle That Targets and Internalizes into Cancer Cells
Daniel A. Truchado, María Juárez-Molina, Sara Rincón, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4327-4327
Open Access | Times Cited: 2
Daniel A. Truchado, María Juárez-Molina, Sara Rincón, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4327-4327
Open Access | Times Cited: 2
Isopeptide Bonding In Planta Allows Functionalization of Elongated Flexuous Proteinaceous Viral Nanoparticles, including Non-Viable Constructs by Other Means
Daniel A. Truchado, Sara Rincón, Lucía Zurita, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 375-375
Open Access | Times Cited: 5
Daniel A. Truchado, Sara Rincón, Lucía Zurita, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 375-375
Open Access | Times Cited: 5
Future Directions of Allergen Immunotherapy for Allergic Rhinitis: Experts’ Perspective
Oliver Pfaar, Jay M. Portnoy, Hendrik Nolte, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 12, Iss. 1, pp. 32-44
Closed Access | Times Cited: 5
Oliver Pfaar, Jay M. Portnoy, Hendrik Nolte, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 12, Iss. 1, pp. 32-44
Closed Access | Times Cited: 5
Antigen-functionalized turnip mosaic virus nanoparticles increase antibody sensing in saliva. A case study with SARS-CoV-2 RBD
Carlos Medrano-Arranz, Sara Rincón, Lucía Zurita, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 109, Iss. 3, pp. 116298-116298
Open Access | Times Cited: 1
Carlos Medrano-Arranz, Sara Rincón, Lucía Zurita, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 109, Iss. 3, pp. 116298-116298
Open Access | Times Cited: 1
Mannan‑, VLP-, and flagellin-based adjuvants for allergen-specific immunotherapy: a review of the current literature
Clara Pignard, H.J. Schiller, Alisa Seyffer, et al.
Allergo Journal International (2024) Vol. 33, Iss. 8, pp. 289-303
Open Access | Times Cited: 1
Clara Pignard, H.J. Schiller, Alisa Seyffer, et al.
Allergo Journal International (2024) Vol. 33, Iss. 8, pp. 289-303
Open Access | Times Cited: 1
Plant virus‐derived nanoparticles decorated with genetically encoded SARS‐CoV‐2 nanobodies display enhanced neutralizing activity
Fernando Merwaiss, Enrique Lozano‐Sanchez, João Zulaica, et al.
Plant Biotechnology Journal (2023) Vol. 22, Iss. 4, pp. 876-891
Open Access | Times Cited: 3
Fernando Merwaiss, Enrique Lozano‐Sanchez, João Zulaica, et al.
Plant Biotechnology Journal (2023) Vol. 22, Iss. 4, pp. 876-891
Open Access | Times Cited: 3
Novel approaches for allergen-specific immunotherapy—An overview
Sakshi Sakshi, Rupa Mazumder, Monika Monika, et al.
Trends in Immunotherapy (2023) Vol. 7, Iss. 1, pp. 2026-2026
Open Access | Times Cited: 2
Sakshi Sakshi, Rupa Mazumder, Monika Monika, et al.
Trends in Immunotherapy (2023) Vol. 7, Iss. 1, pp. 2026-2026
Open Access | Times Cited: 2
Virus-like Particles as Vaccines for Allergen-Specific Therapy: An Overview of Current Developments
Helena Berreiros‐Hortala, Gonzalo Vilchez‐Pinto, Araceli Díaz‐Perales, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7429-7429
Open Access
Helena Berreiros‐Hortala, Gonzalo Vilchez‐Pinto, Araceli Díaz‐Perales, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7429-7429
Open Access
Mannan-, VLP-, and flagellin-based adjuvants for allergen specific immunotherapy: a review of the current literature
Clara Pignard, H.J. Schiller, Alisa Seyffer, et al.
Allergo Journal (2024) Vol. 33, Iss. 8, pp. 34-47
Closed Access
Clara Pignard, H.J. Schiller, Alisa Seyffer, et al.
Allergo Journal (2024) Vol. 33, Iss. 8, pp. 34-47
Closed Access
Turnip Mosaic Virus Nanoparticles: A Versatile Tool in Biotechnology
Daniel A. Truchado, Sara Rincón, Lucía Zurita, et al.
Concepts and strategies in plant sciences (2023), pp. 235-249
Closed Access | Times Cited: 1
Daniel A. Truchado, Sara Rincón, Lucía Zurita, et al.
Concepts and strategies in plant sciences (2023), pp. 235-249
Closed Access | Times Cited: 1
Role of the ligand of Pru p 3 in the allergic sensitization phase
Zulema González Klein
(2023)
Open Access
Zulema González Klein
(2023)
Open Access
